MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The ...
TD Cowen analyst Jason Gabelman lowered the firm’s price target on PBF Energy (PBF) to $19 from $20 and keeps a Sell rating on the shares. The ...
PG&E downgrades to Underweight at Morgan Stanley, joining California utility peer Edison International with the bank's ...
Guggenheim analyst Shahriar Pourreza lowered the firm’s price target on PG&E to $18 from $22 and keeps a Buy rating on the shares. PG&E ...
PG&E reports Q4 results in line with consensus, 2024 adjusted EPS up aided by higher investment, plans to support 5.5 GW of ...
Spotify Technology S.A. 1.21% $128.62B ...
AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D 0.20% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C) 0.31% AGNC Investment Corp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results